nadolol [5529]



nadolol


SMILES CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2
InChIKey VWPOSFSPZNDTMJ-UCWKZMIHSA-N

Chemical Properties

Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 5
Log P 0.635
Molecular weight (Da) 309.2
Stereochemistry info partial

Database connections

Model (Boltz2) β2 β1
Ligand site mutations β3
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

nadolol


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 4
Phase III 2
Phase IV 11

Database connections

Model (Boltz2) β2 β1
Ligand site mutations β3
GPCRdb related ligands

Sankey plot

Drug Information

Target Disease
Gene Protein Receptor family Ligand type Class Name Phase ICD11 ATC Association score